94-65-5Relevant articles and documents
-
Brown,H.C. et al.
, p. 4166 - 4168 (1968)
-
Base-Free Transfer Hydrogenation of Ketones Using Cp?Ir(pyridinesulfonamide)Cl Precatalysts
Ruff, Andrew,Kirby, Christopher,Chan, Benny C.,O'Connor, Abby R.
, p. 327 - 335 (2016/02/19)
N-(2-(Pyridin-2-yl)ethyl)benzenesulfonamide derivatives and 1,1,1-trifluoro-N-(2-(pyridin-2-yl)ethyl)methanesulfonamide (1-4), along with three-legged piano stool Cp?IrIIICl complexes (5-11) (Cp? = pentamethylcyclopentadienyl) bearing pyridinesulfonamide ligands with varying electronic parameters, were synthesized. These ligands and air-stable complexes were characterized by 1H and 13C{1H} NMR spectroscopy, elemental analysis, and single-crystal X-ray diffraction. Precatalysts, 5-11, were assessed for transfer hydrogenation of aryl, diaryl, dialkyl, linear, cycloaliphatic, and α,β-unsaturated ketones, diones, β-ketoesters, and a biomass-derived substrate with 2-propanol, using 1 mol % precatalyst. Catalysis was also efficient using a 0.1 mol % loading. Remarkably, all catalysis experiments can be conducted in air without dried and degassed substrates, and basic additives and halide abstractors are not required for high activity in transfer hydrogenation. Control experiments and a mercury poisoning experiment support a homogeneous catalyzed pathway. Overall, the fastest reactions are observed using electron-poor substrates and precatalysts bearing electron-rich ligands.
TREATMENT FOR ALZHEIMER'S DISEASE AND RELATED CONDITIONS
-
Page/Page column 60, (2010/02/10)
Compounds of formula (I): are useful in the treatment of diseases associated with deposition of β-amyloid in the brain.